Skip to main content
. 2017 Dec 4;12:3449–3456. doi: 10.2147/COPD.S143967

Figure 2.

Figure 2

Rates of roflumilast discontinuation by BMI group.

Notes: In the underweight and normal BMI groups, the rates of roflumilast discontinuation were 41.4% and 45.4%, respectively. On the other hand, in the overweight and obese BMI groups, the roflumilast discontinuation rates were 22.5% and 19.0%, respectively.

Abbreviation: BMI, body mass index.